Lansforsakringar Fondforvaltning AB (publ)

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 2059323 Stockholm, V7

Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$8,689,847

+$921,628 QoQ

Shares Held

256,489

-0.6% QoQ

Ownership

0.022%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#159

of 671 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Lansforsakringar Fondforvaltning AB (publ) holds $29,337,552 across 4 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (29.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	134,828	$9,688,740
2	TEVA	Teva Pharmaceutical Industries Ltd This page	256,489	$8,689,847
3	UTHR	UNITED THERAPEUTICS Corp	11,892	$6,443,442
4	NBIX	Neurocrine Biosciences Inc	26,792	$4,515,523

All Filings in TEVA

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,689,847	256,489	-0.6%	Shares	Sole	2026-08-13
2026-03-31	$7,768,219	257,909	+0.6%	Shares	Sole	2026-04-23
2025-12-31	$8,002,493	256,408	+1.9%	Shares	Sole	2026-02-12
2025-09-30	$5,083,774	251,672	+0.3%	Shares	Sole	2025-11-10
2025-06-30	$4,205,368	250,917	+0.3%	Shares	Sole	2025-08-13
2025-03-31	$3,844,129	250,106	+2.2%	Shares	Sole	2025-05-14
2024-12-31	$5,394,554	244,762	—	Shares	Sole	2025-04-14
No filing history on record for this holder in this stock.